“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Recent advances in targeted therapies for patients with acute myeloid leukemia

€3.03

SKU: product-article-43292 Category: General

Description
Reviews (0)

Description

Recent advances in targeted therapies for patients with acute myeloid leukemia

Reviews

There are no reviews yet.

Be the first to review “Article: Recent advances in targeted therapies for patients with acute myeloid leukemia”

You must be logged in to post a review.

Top

Article: Recent advances in targeted therapies for patients with acute myeloid leukemia

Description

Reviews

Related products

1 year access Online Belgian Journal of Hematology (BJH)

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in melanoma

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer